Protective effects of tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar albino rats
dc.contributor.author | Pinar, Neslihan | |
dc.contributor.author | Karapinar, Oya Soylu | |
dc.contributor.author | Ozcan, Oguzhan | |
dc.contributor.author | Dogan, Esin Atik | |
dc.contributor.author | Bayraktar, Suphi | |
dc.date.accessioned | 2024-09-18T20:53:01Z | |
dc.date.available | 2024-09-18T20:53:01Z | |
dc.date.issued | 2017 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion (I/R) injury in rats. Forty female Wistar albino rats were randomly divided into 5 groups: Group I, sham; Group II, ischemia (I); Group III, I/R; Group IV, I/R + tempol 30 mg/kg i.p; Group V, I/R + tempol 50 mg/kg i.p. Oxidative stress index (OSI) was significantly higher in the ischemia group and the I/R group than in the sham group. Catalase levels were significantly lower in the I/R group than in the I/R + tempol 30 mg/kg i.p. and the I/R + tempol 50 mg/kg i.p. groups. Glutathione peroxidase levels were lower in the I/R group than in the I/R + tempol 30 mg/kg i.p. and the I/R + tempol 50 mg/kg i.p. groups. MDA levels were significantly lower in the I/R + tempol 30 mg/kg i.p. group and the I/R + tempol 50 mg/kg i.p. group than in the I/R group. The levels of the histopathological parameters were significantly decreased in the I/R + tempol 50 mg/kg i.p. group compared with the I/R group. Tempol can be used for reducing ovarian I/R injury. | en_US |
dc.identifier.doi | 10.1139/cjpp-2016-0309 | |
dc.identifier.endpage | 865 | en_US |
dc.identifier.issn | 0008-4212 | |
dc.identifier.issn | 1205-7541 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 28423286 | en_US |
dc.identifier.scopus | 2-s2.0-85021841544 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 861 | en_US |
dc.identifier.uri | https://doi.org/10.1139/cjpp-2016-0309 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/11539 | |
dc.identifier.volume | 95 | en_US |
dc.identifier.wos | WOS:000404738500011 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Canadian Science Publishing | en_US |
dc.relation.ispartof | Canadian Journal of Physiology and Pharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | ovarian ischemia-reperfusion | en_US |
dc.subject | tempol | en_US |
dc.subject | oxidative stress | en_US |
dc.title | Protective effects of tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar albino rats | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1